Crinetics Pharmaceuticals (CRNX) EBT Growth (1y) (2018 - 2026)
Crinetics Pharmaceuticals (CRNX) EBT Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,140.26% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Crinetics Pharmaceuticals | 8.73 Bn | 7.44 Bn | 10.53 Mn | -357.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -357.58% |
| Dec 31, 2025 | -52.16% |
| Sep 30, 2025 | -69.33% |
| Jun 30, 2025 | 56.15% |
| Mar 31, 2025 | 45.61% |
| Dec 31, 2024 | 77.78% |
| Sep 30, 2024 | -236.07% |
| Jun 30, 2024 | 45.27% |
| Mar 31, 2024 | 44.49% |
| Dec 31, 2023 | -906.31% |
| Sep 30, 2023 | 34.67% |
| Jun 30, 2023 | 20.30% |
| Mar 31, 2023 | 36.82% |
| Dec 31, 2022 | 124.39% |
| Sep 30, 2022 | 50.53% |
| Jun 30, 2022 | 62.39% |
| Mar 31, 2022 | 46.79% |
| Dec 31, 2021 | -737.14% |
| Sep 30, 2021 | 173.56% |
| Jun 30, 2021 | 163.84% |